Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a quaternary ammonium compound that acts as an anticholinergic agent. It is poorly absorbed from the gastrointestinal tract.
## Primary Indications
* Adjunctive treatment of peptic ulcers.
* Treatment of irritable bowel syndrome (IBS) or related gastrointestinal disorders characterized by smooth muscle spasm.
## Adult Dosing
* **Peptic Ulcer Disease:** 10 mg to 20 mg three times daily, 30 minutes before meals and at bedtime. Maximum dose is 80 mg daily.
* **Irritable Bowel Syndrome/Gastrointestinal Spasm:** 20 mg three times daily. Maximum dose is 60 mg daily.
## Pediatric Dosing
There is no established pediatric dosing for Walethmade bromide. Use in pediatric patients is generally not recommended due to lack of safety and efficacy data.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Dose reduction may be necessary, though specific guidelines are not well-defined. Monitor closely for anticholinergic side effects.
* **Hepatic Impairment:** No specific dose adjustments are typically recommended, but caution and monitoring are advised.
## Contraindications
* Glaucoma (narrow-angle glaucoma is a specific contraindication).
* Obstructive uropathy (e.g., bladder neck obstruction, prostatic hypertrophy).
* Obstructive gastrointestinal disease (e.g., pyloric stenosis, achalasia).
* Myasthenia gravis.
* Known hypersensitivity to Walethmade bromide or other anticholinergic agents.
## Adverse Effects
Common adverse effects are anticholinergic in nature:
* Dry mouth
* Blurred vision
* Constipation
* Urinary retention
* Drowsiness
* Tachycardia
* Reduced sweating (can lead to heat prostration)
* Confusion (especially in the elderly)
## Key Drug Interactions
* **Other Anticholinergics:** Additive anticholinergic effects, increasing the risk of toxicity.
* **Amantadine:** Increased anticholinergic side effects.
* **Antacids/Adsorbent Laxatives:** May decrease the absorption of Walethmade bromide. Separate administration by at least 1-2 hours.
* **Opioid Analgesics:** Increased risk of severe constipation and paralytic ileus.
* **Potassium Chloride:** Risk of gastrointestinal ulceration with slow-release potassium formulations.
## Monitoring
* Monitor for signs and symptoms of anticholinergic toxicity (e.g., dry mouth, blurred vision, urinary retention, constipation, confusion, tachycardia).
* Assess efficacy in reducing gastrointestinal symptoms.
* Monitor bowel function, especially in elderly patients.
## Clinical Pearls
* Due to its poor absorption, Walethmade bromide may have a lower incidence of systemic anticholinergic side effects compared to other anticholinergics.
* Advise patients to avoid activities requiring mental alertness (e.g., driving) until they know how the medication affects them, as drowsiness can occur.
* Patients should be instructed to report any signs of urinary retention, severe constipation, or vision changes.
* The use of Walethmade bromide for peptic ulcer disease is often considered adjunctive and typically used in conjunction with other therapies like proton pump inhibitors or H2 blockers.
***
**Disclaimer:** This information is intended for healthcare professionals and does not substitute for comprehensive drug information resources. Always verify current prescribing information and consult with appropriate resources before making clinical decisions.
